Since 25‐HC is known to regulate sterol regulatory element‐binding protein (SREBP) expression, and lipid metabolic disorder plays a major role in podocyte injury in DKD,[20] we also examined SREBP1 expression in podocytes but we found that treatment of 25‐HC did not change SREBP1 expression in podocytes (Figure S7, Supporting Information). The gene discussed is SREBF1; the disease is Disorder of lipid metabolism.